Form 8-K - Current report:
SEC Accession No. 0001628280-21-016443
Filing Date
2021-08-10
Accepted
2021-08-10 17:15:51
Documents
3
Period of Report
2021-08-10
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K a2021q28k-er.htm 8-K 31294
2 EX-99.1 a2021q2-ex991er.htm EX-99.1 267960
3 GRAPHIC cumberlandpharmaimageaa06.jpg GRAPHIC 37721
  Complete submission text file 0001628280-21-016443.txt   352424
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 211161037
SIC: 2834 Pharmaceutical Preparations